Hartsough, Edward J.
Thomas Jefferson University · Sidney Kimmel Cancer Center · Drexel University
3 papers on CoChatORCID 0000-0002-5109-3978
Most cited papers
- Verified
Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis
Erkes, D. A., Cai, W., Sanchez, I. M., Purwin, T. J., Rogers, C., Field, C. O., Berger, A. C., Hartsough, E. J., Rodeck, U., Alnemri, E. S., et al. (2020) · Cancer Discovery
Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers
Cited by 459
- Verified
TMIGD1 Is a Novel Adhesion Molecule That Protects Epithelial Cells from Oxidative Cell Injury
Arafa, E., Bondzie, P. A., Rezazadeh, K., Meyer, R. D., Hartsough, E., Henderson, J. M., Schwartz, J. H., Chitalia, V., & Rahimi, N. (2015) · The American Journal of Pathology
Acute Kidney Injury ResearchCell Adhesion Molecules Research
Cited by 40
- Verified
Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo
Hartsough, E. J., Kugel, C. H., Vido, M. J., Berger, A. C., Purwin, T. J., Goldberg, A., Davies, M. A., Schiewer, M. J., Knudsen, K. E., Bollag, G., et al. (2018) · Molecular Cancer Therapeutics
Melanoma and MAPK PathwaysLung Cancer Treatments and Mutations
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free